Tracon Pharmaceuticals
(NASDAQ) TCON
This security has been delisted. This page is retained for historical reference.
TCON News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowTCON Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-57%
Net Income Margin
-30%
Return on Equity
90%
Return on Capital
90%
Return on Assets
-36%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$12.03M
Operating Income
-$6.90M
EBITDA
-$6.88M
Operating Cash Flow
$3.68M
Capital Expenditure
$0.00
Free Cash Flow
$3.68M
Cash & ST Invst.
$8.56M
Total Debt
$968.00K
Tracon Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$55.00K
-99.4%
Gross Profit
$55.00K
-99.4%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
17
N/A
Net Income
-$2.84M
+54.8%
EBITDA
-$2.91M
-180.8%
Quarterly Fundamentals
Net Cash
$6.27M
+505.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-35.51%
N/A
Return on Invested Capital
89.58%
N/A
Free Cash Flow
-$2.77M
+52.7%
Operating Cash Flow
-$2.77M
+52.7%